☰

Laszlo Kopper

Affiliations: 
Semmelweis Egyetem, Hungary 
Area:
Immunology, Biochemistry, Oncology
Google:
"Laszlo Kopper"
Mean distance: (not calculated yet)
 
Tree Publications Similar researchers PubMed Report error

Parents

Sign in to add mentor

Children

Sign in to add trainee
Gabor Barna grad student 2005 Semmelweis Egyetem
Jozsef Batorfi grad student 2005 Semmelweis Egyetem
Rita B. Kovacs grad student 2005 Semmelweis Egyetem
Katalin Nagy grad student 2006 Semmelweis Egyetem
Krisztina Biro grad student 2007 Semmelweis Egyetem

Collaborators

Sign in to add collaborator
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Mátyási B, Farkas Z, Kopper L, et al. (2020) The Function of NM23-H1/NME1 and Its Homologs in Major Processes Linked to Metastasis. Pathology Oncology Research : Por
Sticz T, Molnár A, Dankó T, et al. (2018) The Effects of Different mTOR Inhibitors in EGFR Inhibitor Resistant Colon Carcinoma Cells. Pathology Oncology Research : Por
Sticz T, Molnár A, Márk Á, et al. (2016) mTOR activity and its prognostic significance in human colorectal carcinoma depending on C1 and C2 complex-related protein expression. Journal of Clinical Pathology
Sebestyén A, Márk Á, Hajdu M, et al. (2015) Rapamycin can restore the negative regulatory function of transforming growth factor beta 1 in high grade lymphomas. Cytokine. 73: 219-24
Sebestyén A, Nagy N, Márk Á, et al. (2015) Abstract B47: mTOR C1/2 activities - related protein expression and its potential prognostic/therapeutic importance in certain lymphoid malignancies Molecular Cancer Therapeutics. 14
Schwab R, Petak I, Kollar M, et al. (2014) Major partial response to crizotinib, a dual MET/ALK inhibitor, in a squamous cell lung (SCC) carcinoma patient with de novo c-MET amplification in the absence of ALK rearrangement. Lung Cancer (Amsterdam, Netherlands). 83: 109-11
Márk Á, Hajdu M, Váradi Z, et al. (2013) Characteristic mTOR activity in Hodgkin-lymphomas offers a potential therapeutic target in high risk disease--a combined tissue microarray, in vitro and in vivo study. Bmc Cancer. 13: 250
Nemes K, Sebestyén A, Márk A, et al. (2013) Mammalian target of rapamycin (mTOR) activity dependent phospho-protein expression in childhood acute lymphoblastic leukemia (ALL). Plos One. 8: e59335
Sebestyén A, Sticz TB, Márk A, et al. (2012) Activity and complexes of mTOR in diffuse large B-cell lymphomas--a tissue microarray study. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 25: 1623-8
Kopper L, Sebestyén A, Gallai M, et al. (2012) Syndecan-1 - A new piece in B-cell puzzle. Pathology Oncology Research : Por. 3: 183-91
See more...